midodrine has been researched along with Chronic Liver Failure in 4 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Velez, JC | 1 |
Kadian, M | 1 |
Taburyanskaya, M | 1 |
Bohm, NM | 1 |
Delay, TA | 1 |
Karakala, N | 1 |
Rockey, DC | 1 |
Nietert, PJ | 1 |
Goodwin, AJ | 1 |
Whelan, TP | 1 |
Rajaram, P | 1 |
Spivey, J | 1 |
Fisher, M | 1 |
Dong, T | 1 |
Aronsohn, A | 1 |
Gautham Reddy, K | 1 |
Te, HS | 1 |
Olivera-Martinez, M | 1 |
Martinez, MO | 1 |
Sayles, H | 1 |
Vivekanandan, R | 1 |
D' Souza, S | 1 |
Florescu, MC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Rifaximin Prophylaxis Against Recurrence of Spontaneous Bacterial Peritonitis and Occurrence of Hepatorenal Syndrome in Decompensated Cirrhotic Egyptian Patients[NCT05621005] | Phase 2 | 104 participants (Actual) | Interventional | 2019-03-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for midodrine and Chronic Liver Failure
Article | Year |
---|---|
Hepatorenal Acute Kidney Injury and the Importance of Raising Mean Arterial Pressure.
Topics: Acute Kidney Injury; Aged; Arterial Pressure; Creatinine; End Stage Liver Disease; Female; Hepatoren | 2015 |
Novel role of midodrine in pulmonary hypertension in liver transplant candidates.
Topics: Adrenergic alpha-1 Receptor Agonists; End Stage Liver Disease; Female; Humans; Hypertension, Portal; | 2016 |
Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Case-Control Studies; End Stage Liver Disease; Fem | 2016 |
Hepatorenal syndrome: are we missing some prognostic factors?
Topics: Albumins; Alcoholism; Autoimmune Diseases; Creatinine; End Stage Liver Disease; Female; Hepatitis C; | 2012 |